Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics

OBJECTIVE: Second-generation antipsychotics (SGAs) increase the risk of metabolic syndrome (MetS). Despite the risk of MetS, SGAs may have to be continued with change in some patients. The aim of this study was to trace the evolution of MetS in these patients. METHODS: Patients with schizophrenia wh...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Psychiatry Investig
Main Authors: Jeong, Seong Hoon, Lee, Nam Young, Kim, Se Hyun, Chung, In Won, Youn, Tak, Kang, Ung Gu, Ahn, Yong Min, You, Han Young, Kim, Yong Sik
Format: Artigo
Jezik:Inglês
Izdano: Korean Neuropsychiatric Association 2018
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018140/
https://ncbi.nlm.nih.gov/pubmed/29940717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30773/pi.2018.01.18.1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki